相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -Withania somnifera(Ashwagandha),Tinospora cordifolia(Giloy) andOcimum sanctum(Tulsi) - a molecular docking study
Priya Shree et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations
Aditya K. Padhi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Meng-Yuan Li et al.
INFECTIOUS DISEASES OF POVERTY (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings
Rajkumar Singh Kalra et al.
PATHOGENS (2020)
Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
Hoang Linh Nguyen et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Roles of flavonoids against coronavirus infection
Maria Russo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee et al.
PHARMACOLOGICAL RESEARCH (2020)
Withaferin A: a potential therapeutic agent against COVID-19 infection
Alex R. Straughn et al.
JOURNAL OF OVARIAN RESEARCH (2020)
Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
Amanat Ali et al.
SCIENTIFIC REPORTS (2020)
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Sylwester Drozdzal et al.
DRUG RESISTANCE UPDATES (2020)
Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
Ziyad Tariq Muhseen et al.
JOURNAL OF MOLECULAR LIQUIDS (2020)
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
Qi Zhang et al.
CELL DISCOVERY (2020)
Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19
Shalki Choudhary et al.
VIRUS RESEARCH (2020)
Molecular Insights Into Withaferin-A-Induced Senescence: Bioinformatics and Experimental Evidence to the Role of NFκB and CARF
Priyanshu Bhargava et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Wild type p53 function in p53Y220C mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence
Durai Sundar et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
Alex R. Straughn et al.
JOURNAL OF OVARIAN RESEARCH (2019)
2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences
Anupama Chaudhary et al.
SCIENTIFIC REPORTS (2019)
Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost
Amandeep Kaur et al.
PLOS ONE (2018)
Withaferin a associated Differential regulation of inflammatory cytokines
Seema Dubey et al.
FRONTIERS IN IMMUNOLOGY (2018)
Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
Rameshwar U. Kadam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
2,3-Dihydro-3β-methoxy Withaferin-A Protects Normal Cells against Stress: Molecular Evidence of Its Potent Cytoprotective Activity
Anupama Chaudhary et al.
JOURNAL OF NATURAL PRODUCTS (2017)
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
Yue Yu et al.
CELL DEATH & DISEASE (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts
Sunil C. Kaul et al.
PLOS ONE (2016)
Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study
Zhi Cai et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Withanone-Rich Combination of Ashwagandha Withanolides Restricts Metastasis and Angiogenesis through hnRNP-K
Ran Gao et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Withanone binds to mortalin and abrogates mortalin-p53 complex: Computational and experimental evidence
Abhinav Grover et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus
Kailang Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ashwagandha Derived Withanone Targets TPX2-Aurora A Complex: Computational and Experimental Evidence to its Anticancer Activity
Abhinav Grover et al.
PLOS ONE (2012)
AN OVERVIEW ON ASHWAGANDHA: A RASAYANA (REJUVENATOR) OF AYURVEDA
Narendra Singh et al.
AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES (2011)
Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A
Abhinav Grover et al.
BMC BIOINFORMATICS (2011)
Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS Signaling
Nashi Widodo et al.
PLOS ONE (2010)
Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections
Fang Li
JOURNAL OF VIROLOGY (2008)
Selective killing of cancer cells by leaf extract of ashwagandha: Identification of a tumor-inhibitory factor and the first molecular insights to its effect
Nashi Widodo et al.
CLINICAL CANCER RESEARCH (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Characterization of a novel coronavirus associated with severe acute respiratory syndrome
PA Rota et al.
SCIENCE (2003)
分享论文
